Vishakh Kharat – Neovant Therapeutics Pvt. Ltd.
View Detailed Executive Profile →Professional Overview
- Vishakh Kharat has founded Neovant Therapeutics Pvt. Ltd., serving as the Executive Director since September 2023, marking a significant step in their career by taking on a leadership role in a new venture.
- Prior to establishing Neovant Therapeutics, Kharat worked at Piramal Pharma Solutions from June 2015 to September 2023, specializing in formulations for injectable R&D and API large molecules, contributing to advancements in therapeutic solutions.
- From 2010 to 2015, Kharat held the position of General Manager of Research and Development at Mylan Laboratories Limited, overseeing innovative research projects and product development initiatives in the pharmaceutical sector.
- Kharat’s career also includes experience as a Principal Scientist at Pfizer from May 2007 until May 2010, where duties involved leading research initiatives and contributing to key pharmaceutical discoveries.
- At Advinus Therapeutics, a TATA enterprise, Kharat served as AGM Manager from October 2006 to May 2007, gaining extensive experience in managing research projects in a notable industry setting.
- Additionally, Kharat worked as a Manager at Dr. Reddy's Laboratories from October 2003 until September 2006, responsible for overseeing research operations and driving project success.
- The journey began as a Research Officer at Glenmark Pharmaceuticals Ltd from January 2000 to January 2003, providing a solid foundation in pharmaceutical research and development.
- Kharat’s extensive experience in both leadership and technical roles within various prominent pharmaceutical companies positions them as a key figure in the development of innovative therapeutic strategies in the industry.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Advinus Therapeutics- A TATA Enterprise | AGM.Manager | Oct 2006 – May 2007 |
| Dr. Reddys Laboratories Ltd | Manager | Oct 2003 – Sep 2006 |
| Pfizer | Principal Scientist | May 2007 – Nov 2010 |
| Piramal Pharma Solutions | Formulations (injectable R&D)and API large molecules , Material Characterization | Jun 2015 – Sep 2023 |
| Mylan Laboratories Limited | General Manager Research and Development | Jan 2010 – Jan 2015 |
| Glenmark Pharmaceuticals Ltd | Research officer | Jan 2000 – Jan 2003 |
| Neovant Therapeutics Pvt. Ltd. | Founder and Executive Director | Sep 2023 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Neovant Therapeutics Pvt. Ltd. corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Vishakh Kharat's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Neovant Therapeutics Pvt. Ltd.'s official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)